Risk of gestational hypertension in women treated with serotonin and norepinephrine reuptake inhibitors: A comparative study in the EFEMERIS database

被引:0
|
作者
Lacroix, Isabelle [1 ]
Araujo, Melanie [2 ]
Waser, Julie [3 ]
Hurault Delarue, Caroline [2 ]
Damase Michel, Christine [4 ]
机构
[1] Univ Toulouse, CHU Toulouse, INSERM 1027, Toulouse, France
[2] Ctr Hosp Univ Toulouse, Reseau Regards Pharmacol Med & Clin, Inserm Umr 1295 Cerpop Equipe Sphere, Toulouse, France
[3] Ctr Hosp Univ Toulouse, Pharmacol Med & Clin, Inserm Umr 1295 Cerpop Equipe Sphere, Toulouse, France
[4] Univ Toulouse III, Fac Med, Pharmacol Med, Inserm CERPOP,CHU, Toulouse, France
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
535
引用
收藏
页码:239 / 240
页数:2
相关论文
共 50 条
  • [21] Moderate Alcohol Consumption Increases the Risk of Clinical Relapse in Male Depressed Patients Treated with Serotonin-Norepinephrine Reuptake Inhibitors
    Musat, Madalina Iuliana
    Militaru, Felicia
    Gheorman, Victor
    Udristoiu, Ion
    Mitran, Smaranda Ioana
    Catalin, Bogdan
    DIAGNOSTICS, 2024, 14 (11)
  • [22] Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
    Chambers, CD
    Hernandez-Diaz, S
    Van Marter, LJ
    Werler, MM
    Louik, C
    Jones, KL
    Mitchell, AA
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06): : 579 - 587
  • [23] Safety of neuraminidase inhibitors, oseltamivir and zanamivir, during pregnancy: a comparative study in the EFEMERIS database
    Lacroix, I.
    Beau, A. B.
    Hurault-Delarue, C.
    Montastruc, J. L.
    Damase-Michel, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 106 - 106
  • [24] Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis
    Sanz, EJ
    De-las-Cuevas, C
    Kiuru, A
    Bate, A
    Edwards, R
    LANCET, 2005, 365 (9458): : 482 - 487
  • [25] Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis
    Renoux, Christel
    Lix, Lisa M.
    Patenaude, Valerie
    Bresee, Lauren C.
    Paterson, J. Michael
    Lafrance, Jean-Philippe
    Tamim, Hala
    Mahmud, Salaheddin M.
    Alsabbagh, Mhd. Wasem
    Hemmelgarn, Brenda
    Dormuth, Colin R.
    Ernst, Pierre
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (10): : 1716 - 1722
  • [26] A comparative analysis of selective serotonin reuptake inhibitors and fall risk in older adults
    Haddad, Yara K.
    Kakara, Ramakrishna
    Marcum, Zachary A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (05) : 1450 - 1460
  • [27] Meta-analysis examining the efficacy of serotonin and/or norepinephrine reuptake inhibitors in the treatment of women with hot flashes
    Mukherjee, S. D.
    Strohm, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [28] Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study
    Donneyong, Macarius M.
    Bykov, Katsiaryna
    Bosco-Levy, Pauline
    Dong, Yaa-Hui
    Levin, Raisa
    Gagne, Joshua J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [29] The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications
    Viguera, Adele C.
    Jones, Alexia
    Szpunar, Mercedes J.
    Bernstein, Sarah N.
    Killenberg, Parker C.
    Sojka, Ellen T.
    Rossa, Ella T.
    Gaccione, Peter
    Freeman, Marlene P.
    Cohen, Lee S.
    JOURNAL OF WOMENS HEALTH, 2024, 33 (12) : 1606 - 1613
  • [30] Comparison of safety signals between selective serotonin-reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRI) employing FDA adverse event reporting system (FAERS) database
    Titus, Christa
    Maheswari, Eswaran
    Subeesh, Viswam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 182 - 182